FFS
ABBV icon

Founders Financial Securities’s AbbVie ABBV Stock Holding History

Founders Financial Securities’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.47M Buy
9,802
+4,910
+100% +$1.06M 0.13% 159
2026
Q1 		$1.04M Sell
4,892
-850
-15% -$189K 0.06% 281
2025
Q4 		$1.31M Buy
5,742
+1,182
+26% +$269K 0.08% 248
2025
Q3 		$1.06M Sell
4,560
-500
-10% -$102K 0.07% 244
2025
Q2 		$939K Buy
5,060
+54
+1% +$10K 0.07% 245
2025
Q1 		$963K Buy
5,006
+685
+16% +$133K 0.08% 225
2024
Q4 		$768K Sell
4,321
-117
-3% -$21.5K 0.07% 215
2024
Q3 		$876K Sell
4,438
-1,725
-28% -$322K 0.08% 196
2024
Q2 		$1.06M Buy
6,163
+1,599
+35% +$265K 0.1% 172
2024
Q1 		$831K Sell
4,564
-307
-6% -$52.9K 0.09% 187
2023
Q4 		$755K Buy
4,871
+853
+21% +$124K 0.08% 198
2023
Q3 		$599K Buy
4,018
+362
+10% +$53.1K 0.08% 193
2023
Q2 		$493K Buy
3,656
+247
+7% +$36.2K 0.07% 215
2023
Q1 		$543K Sell
3,409
-131
-4% -$20K 0.08% 193
2022
Q4 		$572K Sell
3,540
-357
-9% -$54.7K 0.09% 185
2022
Q3 		$523K Buy
3,897
+324
+9% +$46.5K 0.09% 174
2022
Q2 		$547K Sell
3,573
-27
-0.8% -$4.13K 0.11% 153
2022
Q1 		$584K Buy
3,600
+59
+2% +$8.57K 0.1% 160
2021
Q4 		$479K Sell
3,541
-54
-2% -$6.38K 0.09% 175
2021
Q3 		$388K Buy
3,595
+171
+5% +$19.5K 0.08% 191
2021
Q2 		$386K Buy
3,424
+55
+2% +$6.19K 0.08% 201
2021
Q1 		$365K Sell
3,369
-719
-18% -$76.9K 0.08% 181
2020
Q4 		$438K Buy
4,088
+1,635
+67% +$157K 0.1% 139
2020
Q3 		$215K Sell
2,453
-2,595
-51% -$244K 0.07% 152
2020
Q2 		$490K Buy
+5,048
New +$444K 0.16% 99

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Founders Financial Securities's ABBV Position: Q2 2026 in Review

Founders Financial Securities increased its AbbVie (ABBV) stake by 100% in Q2 2026, buying an estimated $1.06M and bringing the position to 9,802 shares worth $2.47M. The position accounts for 0.13% of the portfolio, ranked #159.

Founders Financial Securities first reported a position in ABBV in Q2 2020 and has held it in 25 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Founders Financial Securities held 9,802 shares of AbbVie worth $2.47M as of Q2 2026.
  • Founders Financial Securities bought 4,910 AbbVie shares in Q2 2026, an estimated $1.06M.
  • AbbVie made up 0.13% of Founders Financial Securities's portfolio in Q2 2026, its #159 holding.
  • Founders Financial Securities first reported a position in AbbVie in Q2 2020 and has held it in 25 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Founders Financial Securities's 13F filing for Q2 2026, filed 31 Jul 2026.